RENEE NGO: Open Payments
NPI 1902889264 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$736 in 32 payments from 6 companies in 2025. Trend: 2023 $723 · 2024 $730 · 2025 $736
Food & beverage: $736
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 14 | $348 |
| E.R. Squibb & Sons, L.L.C. | 6 | $151 |
| Lundbeck LLC | 6 | $116 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $57 |
| Alkermes, Inc. | 2 | $46 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
Products named: REXULTI, COBENFY, ABILIFY ASIMTUFII, CAPLYTA, ARISTADA, FANAPT.
Industry payments across NV — which companies pay providers there.
